J.B. Chemicals & Pharmaceuticals Limited is a leading pharmaceutical company based in India. With a rich heritage of over four decades, the company has established itself as a trusted provider of high-quality pharmaceutical products and healthcare solutions. The company operates in various segments of the pharmaceutical industry, including formulations, active pharmaceutical ingredients (APIs), and branded generics. The company has a diverse product portfolio encompassing a wide range of therapeutic areas such as cardiovascular, respiratory, central nervous system, anti-infective, and gastrointestinal.
- J.B. Chemicals & Pharmaceuticals Limited reported Total Income for Q4 FY23 of ₹766.90 Crore up from ₹626.67 Crore year on year, a growth of 22.4%.
- Total Expenses for Q4 FY23 of ₹644.44 Crore up from ₹523.39 Crore year on year, a growth of 23.1%.
- Consolidated Net Profit of ₹87.63 Crore, up 3% from ₹84.97 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹11.19, up from ₹10.96 in the same quarter of the previous year.